Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuching Yang

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|November 18, 2020
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical PharmacologyXinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Pharmaceutical Research|March 4, 2025
Considerations for Regulatory Reusability of Dynamic Tools in the New Drug DevelopmentJiang Liu, Yuching Yang, Joga Gobburu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2012
Cross-species transcriptomic analysis of mouse and rat lung exposed to chloropreneRussell S Thomas, Matthew W Himmelstein, Harvey J Clewell, et al.
Journal of Women'S Health (2002)|December 14, 2011
Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot studyChrisandra Shufelt, C Noel Bairey Merz, YuChing Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2012
An analysis of N-acetylcysteine treatment for acetaminophen overdose using a systems model of drug-induced liver injuryJeffrey L Woodhead, Brett A Howell, Yuching Yang, et al.
Journal of Clinical Pharmacology|November 9, 2023
Model-Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory PerspectiveXiaolei Pan, Li Wang, Jiang Liu, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 26, 2019
Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and SimulationColleen Kuemmel, Yuching Yang, Xinyuan Zhang, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ DysfunctionJianghong Fan, Yuching Yang, Manuela Grimstein, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 4, 2023
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary reportAbdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019Jianghong Fan, Xinyuan Zhang, Jiang Liu, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|November 18, 2020
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical PharmacologyXinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Pharmaceutical Research|March 4, 2025
Considerations for Regulatory Reusability of Dynamic Tools in the New Drug DevelopmentJiang Liu, Yuching Yang, Joga Gobburu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2012
Cross-species transcriptomic analysis of mouse and rat lung exposed to chloropreneRussell S Thomas, Matthew W Himmelstein, Harvey J Clewell, et al.
Journal of Women'S Health (2002)|December 14, 2011
Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot studyChrisandra Shufelt, C Noel Bairey Merz, YuChing Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 18, 2012
An analysis of N-acetylcysteine treatment for acetaminophen overdose using a systems model of drug-induced liver injuryJeffrey L Woodhead, Brett A Howell, Yuching Yang, et al.
Journal of Clinical Pharmacology|November 9, 2023
Model-Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory PerspectiveXiaolei Pan, Li Wang, Jiang Liu, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 26, 2019
Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and SimulationColleen Kuemmel, Yuching Yang, Xinyuan Zhang, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ DysfunctionJianghong Fan, Yuching Yang, Manuela Grimstein, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 4, 2023
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary reportAbdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019Jianghong Fan, Xinyuan Zhang, Jiang Liu, et al.
Pageof 5